Search Results 531-540 of 13949 for alp

  1. Functional ElectroAnatomiC Isochronal Late Activation Mapping For Empiric VT Ablation Trial - Mayo Clinic

    About this study. This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guided VT ablation ...

  2. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

    ... Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within 14 days of study ...

  3. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    Alkaline phosphatase =< 3 x ULN (=< 5 x ULN if liver or bone involvement); Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1 ...

  4. Fat Emulsion In Preventing Hypersensitivity Reactions In Patients With Cancer Receiving Carboplatin Or Oxaliplatin - Mayo Clinic

    Alkaline phosphatase =< 3 x the institutional upper limit of normal. Exclusion Criteria: Concurrent liposomal doxorubicin or any other liposomal agent; Prior ...

  5. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

    Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl. PT 11.7 -14.3 (During Liposyn/heparin infusion, PT will be determined to ...

  6. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

    ... alkaline phosphatase must be < 2.5 x ULN; Within 2 weeks prior to randomization, there must be postoperative evidence of adequate hepatic function; aspartate ...

  7. A Study To Evaluate The Long-Term Safety And Effectiveness Of Ubenimex In Patients With Pulmonary Arterial Hypertension - Mayo Clinic

    About this study. The purpose of this study is to evaluate the long-term safety, tolerability, and effectiveness of ubenimex for the treatment of patients ...

  8. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Serum alkaline phosphatase ≤ 3x ULN (upper limit of normal)in the absence of liver or bone metastases or ≤5 ULN(in patients with documented bone or liver ...

  9. CSF1R And TAM Receptor Inhibition With Q702 - Mayo Clinic

    Alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) ≤2.5 x ULN (≤5 x ULN for patients with liver involvement).

  10. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    NOTE: Patients with elevated alkaline phosphatase, calcium or suspicious bone pain/tenderness should also undergo baseline bone scans to evaluate for bone ...